1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South and Central America Anti-Infective Agents Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South and Central America Anti-Infective Agents Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South and Central America Anti-Infective Agents Market Regional Analysis
6.2 South and Central America Anti-Infective Agents Market Revenue 2020-2028 (US$ Million)
6.3 South and Central America Anti-Infective Agents Market Forecast Analysis
7. South and Central America Anti-Infective Agents Market Analysis – by Type
7.1 Anti-Viral
- 7.1.1 Overview
- 7.1.2 Anti-Viral: South and Central America Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Anti-Bacterial
- 7.2.1 Overview
- 7.2.2 Anti-Bacterial: South and Central America Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Anti-Fungal
- 7.3.1 Overview
- 7.3.2 Anti-Fungal: South and Central America Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. South and Central America Anti-Infective Agents Market Analysis – by Range
8.1 Narrow Spectrum and Broad Spectrum
- 8.1.1 Overview
- 8.1.2 Narrow Spectrum and Broad Spectrum: South and Central America Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. South and Central America Anti-Infective Agents Market Analysis – by Route of Administration
9.1 IV
- 9.1.1 Overview
- 9.1.2 IV: South and Central America Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Oral
- 9.2.1 Overview
- 9.2.2 Oral: South and Central America Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Topical
- 9.3.1 Overview
- 9.3.2 Topical: South and Central America Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. South and Central America Anti-Infective Agents Market Analysis – by Indication
10.1 HIV
- 10.1.1 Overview
- 10.1.2 HIV: South and Central America Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.2 Tuberculosis
- 10.2.1 Overview
- 10.2.2 Tuberculosis: South and Central America Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.3 Respiratory Infection
- 10.3.1 Overview
- 10.3.2 Respiratory Infection: South and Central America Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.4 Pneumonia
- 10.4.1 Overview
- 10.4.2 Pneumonia: South and Central America Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
11. South and Central America Anti-Infective Agents Market – South and Central America Analysis
11.1 Overview
11.2 South and Central America
- 11.2.1 South and Central America Anti-Infective Agents Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 11.2.1.1 South and Central America Anti-Infective Agents Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 Brazil:
South and Central America Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 Brazil: South and Central America Anti-Infective Agents Market Breakdown, by Type
- 11.2.1.1.2 Brazil: South and Central America Anti-Infective Agents Market Breakdown, by Range
- 11.2.1.1.3 Brazil: South and Central America Anti-Infective Agents Market Breakdown, by Route of Administration
- 11.2.1.1.4 Brazil: South and Central America Anti-Infective Agents Market Breakdown, by Indication
- 11.2.1.2 Argentina:
South and Central America Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Argentina: South and Central America Anti-Infective Agents Market Breakdown, by Type
- 11.2.1.2.2 Argentina: South and Central America Anti-Infective Agents Market Breakdown, by Range
- 11.2.1.2.3 Argentina: South and Central America Anti-Infective Agents Market Breakdown, by Route of Administration
- 11.2.1.2.4 Argentina: South and Central America Anti-Infective Agents Market Breakdown, by Indication
- 11.2.1.3 Rest of South and Central America :
South and Central America Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Rest of South and Central America : South and Central America Anti-Infective Agents Market Breakdown, by Type
- 11.2.1.3.2 Rest of South and Central America : South and Central America Anti-Infective Agents Market Breakdown, by Range
- 11.2.1.3.3 Rest of South and Central America : South and Central America Anti-Infective Agents Market Breakdown, by Route of Administration
- 11.2.1.3.4 Rest of South and Central America : South and Central America Anti-Infective Agents Market Breakdown, by Indication
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Allergan Plc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Astellas Pharma Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Bayer AG
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Boehringer Ingelheim International GmbH
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Bristol-Myers Squibb Company
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 F. Hoffmann-La Roche Ltd.
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Gilead Sciences, Inc.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 GlaxoSmithKline plc.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Merck & Co., Inc.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Novartis AG
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For South and Central America Anti-Infective Agents Market
